HealthStream (HSTM) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap health care technology companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

Do insiders and institutionals hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 2.5% of Omnicell shares are held by insiders. Comparatively, 20.6% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.89% compared to Omnicell's net margin of 2.01%. HealthStream's return on equity of 5.70% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	2.01%	4.27%	2.44%
HealthStream	6.89%	5.70%	3.99%

Which has stronger earnings and valuation, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.25	$12.53M	$0.50	60.40
HealthStream	$291.65M	2.74	$20.01M	$0.67	40.28

Does the media favor OMCL or HSTM?

In the previous week, HealthStream had 1 more articles in the media than Omnicell. MarketBeat recorded 1 mentions for HealthStream and 0 mentions for Omnicell. Omnicell's average media sentiment score of 1.00 beat HealthStream's score of 0.24 indicating that Omnicell is being referred to more favorably in the media.

Company	Overall Sentiment
Omnicell	Positive
HealthStream	Neutral

Do analysts prefer OMCL or HSTM?

Omnicell presently has a consensus target price of $46.71, suggesting a potential upside of 54.68%. HealthStream has a consensus target price of $31.00, suggesting a potential upside of 14.86%. Given Omnicell's higher probable upside, research analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
HealthStream	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Which has more risk and volatility, OMCL or HSTM?

Omnicell has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.

Summary

HealthStream beats Omnicell on 9 of the 16 factors compared between the two stocks.